Nephrology
Conference Coverage
Two biomarkers identify high-risk lupus nephritis
Two biomarkers, elastase-DNA and HMGB1-DNA, correlate with poor outcomes in patients with lupus nephritis.
From the Journals
Fair access crucial for new diabetes/kidney disease drugs, say guidelines
A 2022 guideline for treating diabetes in people with chronic kidney disease highlighted the proven value of three underused drug classes and...
From the Journals
Dapagliflozin reduces hospitalizations in patients with CKD
A new analysis adds to a growing body of evidence supporting a range of positive benefits from dapagliflozin.
News from the FDA/CDC
FDA alert: ‘Substantial’ hypocalcemia risk with denosumab use in dialysis patients
The Food and Drug Administration sent an alert that it’s investigating an apparent link between the use of denosumab (Prolia) by patients on...
Conference Coverage
Dialysis not always best option in advanced kidney disease
“We’ve recognized for a long time that there are many patients for whom dialysis provides neither a survival advantage nor a quality of life...
Latest News
Promising new antibiotic emerges for treating UTIs
It would be the first new treatment in 20 years for UTIs, which affect more than half of women at least sometime in their lives.
Conference Coverage
Study sheds new light on RAS inhibitors’ role for advanced CKD
“The results of this trial will inform future clinical practice worldwide and guideline recommendations.”
From the Journals
Kidney function may help docs pick antiplatelet mix after stroke
Ticagrelor–aspirin compared with clopidogrel-aspirin reduced risk for recurrent stroke with no substantial increase in severe or moderate bleeding...
From the Journals
Goodbye ‘diabetes insipidus’, hello ‘AVP-D’ and ‘AVP-R’
Confusion with the term ‘diabetes mellitus’ ... has spurred proposed name change by an international panel representing major endocrinology...
From the Journals
Islet transplants in type 1 diabetes durable up to 8 years
Long-term insulin independence and safety is seen with islet-cell transplant in patients with severe hypoglycemia at baseline.
From the Journals
‘Too good to be true’? Ultrasound safely treats kidney stones
The results of limited patient discomfort and stone motion in 66% of treated patients seem “almost too good to be true.”